Home/Pipeline/TAH7702

TAH7702

Schizophrenia (Antipsychotic patch)

Phase 1Active

Key Facts

Indication
Schizophrenia (Antipsychotic patch)
Phase
Phase 1
Status
Active
Company

About TAHO Pharmaceuticals

TAHO Pharma delivers novel transdermal and oral‑film drug formats to address unmet patient needs across cardiovascular, neurology, and oncology markets.

View full company profile